Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $17.00 price target on the biopharmaceutical company’s stock.
Palatin Technologies Trading Up 0.8 %
NYSEAMERICAN PTN traded up $0.01 on Thursday, reaching $1.27. The company had a trading volume of 154,073 shares, compared to its average volume of 354,457. The firm has a market capitalization of $24.83 million, a P/E ratio of -0.59 and a beta of 0.99. Palatin Technologies has a 52-week low of $0.68 and a 52-week high of $5.65.
Palatin Technologies (NYSEAMERICAN:PTN – Get Free Report) last released its quarterly earnings results on Tuesday, October 1st. The biopharmaceutical company reported ($0.51) earnings per share for the quarter. As a group, sell-side analysts predict that Palatin Technologies will post -2.03 EPS for the current fiscal year.
Institutional Trading of Palatin Technologies
Palatin Technologies Company Profile
Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.
Further Reading
- Five stocks we like better than Palatin Technologies
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- What is an Earnings Surprise?
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Airline Stocks – Top Airline Stocks to Buy Now
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Palatin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palatin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.